<?xml version="1.0"?>
<Articles JournalTitle="Journal of Pharmaceutical Care">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Pharmaceutical Care</JournalTitle>
      <Issn>2322-4630</Issn>
      <Volume>9</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2021</Year>
        <Month>09</Month>
        <Day>28</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A Review of Severe Acute Respiratory Syndrome Coronavirus 2 and Pathological Disorders in Patients</title>
    <FirstPage>141</FirstPage>
    <LastPage>147</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Ghorbat Saleh</FirstName>
        <LastName>Ali</LastName>
        <affiliation locale="en_US">Department of Biology, Collage of Science, University of Duhok, Duhok, Iraq.</affiliation>
      </Author>
      <Author>
        <FirstName>Betul</FirstName>
        <LastName>Ozdemir</LastName>
        <affiliation locale="en_US">Department of Cardiology, Faculty of Medicine, Nigde Omer Halisdemir University, Campus, 51240, Nigde, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Zeliha</FirstName>
        <LastName>Selamoglu</LastName>
        <affiliation locale="en_US">Department of Medical Biology, Faculty of Medicine, Nigde &#xD6;mer Halisdemir University, Nigde, Turkey.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>05</Month>
        <Day>10</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>07</Month>
        <Day>26</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Firstly, a new coronavirus emerged in Wuhan, China, sparking a pandemic of acute respiratory syndrome in humans. Corona virus disease-19 (COVID-19) was declared as a pandemic after the infection spread globally and disease caused by the new type of coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was named as COVID-19. The virus originated from bats and has been passed to humans. Initially, SARS-CoV-19 infects respiratory system an acute serious&#xA0;viral infection mainly&#xA0;developed with over a million people worldwide were transmitted rapidly in a few months. SARS-CoV-19, progress&#xA0;a moderate&#xA0;to&#xA0;serious&#xA0;severe respiratory symptoms such as headache, cough, and breathlessness. Also, digestive system symptoms include nausea, vomiting, and stomach pain.&#xA0; Although the precise of the mechanism of inflammation unclear but this virus firstly use the angiotensin converting enzyme 2 (ACE2) receptor of the alveolar cells of lung tissue causing inflammation and cell death.&#xA0; Then&#xA0;virus&#xA0;spreads&#xA0;and&#xA0;affects&#xA0;other&#xA0;important&#xA0;organ&#xA0;and&#xA0;tissues&#xA0;with complex pathophysiological alterations, the coronary disease, pulmonary disease, chronic kidney disease and chronic liver disease are the most prevalent comorbidities among patients. In COVID-19 infection therapy lots agents recommended. Unfortunately, there is no clear effective drug for treatment. This review presented potential pathogenic pathway of the SARS-CoV-19 infection and symptoms in the patients and given the information about the negative effects on different systems in the respiratory, cardiac system, nervous system, gastrointestinal system, and urinary tract.</abstract>
    <web_url>https://jpc.tums.ac.ir/index.php/jpc/article/view/422</web_url>
  </Article>
</Articles>
